Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development | News
Search Refinements

Drug Discovery & Development News

View news from other Pharmaceutical sectors:
136-150 of 4506 results
Google’s venture arm leads $51.7m investment in Spero Therapeutics
Spero Therapeutics, a biopharmaceutical firm engaged in the development of novel therapies to treat bacterial infections, has completed a $51.7m Series C preferred financing led by new investor GV (formerly Google Ventures).
Drug Research > Drug Discovery & Development > News
Heat Biologics to acquire controlling stake in Pelican Therapeutics
Heat Biologics has agreed to buy an 80% controlling stake in Pelican Therapeutics, a privately held immuno-oncology company engaged in the development of agonists to TNFRSF25, a differentiated T cell costimulatory receptor.
Drug Research > Drug Discovery & Development > News
Bioversys, Aptuit partner to find novel antibiotic targets
Bioversys and Aptuit have commenced their joint collaboration to identify and validate novel targets and molecules for Gram-negative bacteria.
Drug Research > Drug Discovery & Development > News
Vertex to buy cystic fibrosis drug from Concert Pharmaceuticals
Vertex Pharmaceuticals has agreed to acquire CTP-656 from Concert Pharmaceuticals to treat cystic fibrosis.
Drug Research > Drug Discovery & Development > News
FDA accepts Advaxis' IND for personalized neoepitope immunotherapy ADXS-NEO
The US Food and Drug Administration (FDA) has accepted Advaxis’ Investigational New Drug (IND) application for ADXS-NEO, a personalized neoantigen-targeted approach to cancer immunotherapy that is being developed in partnership with Amgen.
Drug Research > Drug Discovery & Development > News
AstraZeneca’s MedImmune, Sanofi partner to develop infant respiratory drug
By PBR Staff Writer
AstraZeneca’s biologics research and development arm MedImmune and Sanofi Pasteur have agreed to a potential €615m collaboration to develop a monoclonal antibody (mAb) treatment for respiratory syncytial virus (RSV).
Drug Research > Drug Discovery & Development > News
Abzena, UCL secure £3.5m grant from MRC for autoimmune therapy research
A research group from University College London's (UCL) Centre for Rheumatology has been awarded a £3.5m grant from the Medical Research Council (MRC) to advance the development of a novel treatment for anti-phospholipid syndrome (APS) based on Abzena's conjugation technology.
Drug Research > Drug Discovery & Development > News
Astellas, Affinivax to develop MAPS vaccine targeting pneumococcal disease
Affinivax and Astellas Pharma have signed an exclusive worldwide license agreement to develop and market a vaccine targeting Streptococcus pneumoniae (pneumococcus).
Drug Research > Drug Discovery & Development > News
WHO reaffirms critical need for R&D for drug-resistant tuberculosis
The World Health Organization (WHO) has stressed the urgent requirement for research and development (R&D) of new antibiotics to handle the threat posed by drug-resistant tuberculosis (TB).
Drug Research > Drug Discovery & Development > News
Pharma Two B raises $30m for trial of Parkinson's treatment
Pharma Two B, a privately held biopharmaceutical firm engaged in the development of treatments for Parkinson’s disease, has closed $30m financing round.
Drug Research > Drug Discovery & Development > News
Advaxis licenses antigen delivery technology to Sellas for cancer immunotherapy development
Advaxis has licensed its Lm-based antigen delivery technology to Sellas, under a cancer immunotherapy collaboration that could generate up to $358m for Advaxis.
Drug Research > Drug Discovery & Development > News
Incyte partners with University of Pennsylvania on cancer immunotherapy research
Incyte has entered into multi-year research collaboration with the Abramson Cancer Center at the University of Pennsylvania.
Drug Research > Drug Discovery & Development > News
PMV Pharma raises $74m for cancer drugs targeting p53
PMV Pharmaceuticals, which is engaged in the discovery and development of p53-targeted small molecule drugs for the treatment of cancer, has completed a $74m Series B financing round.
Drug Research > Drug Discovery & Development > News
Modus Therapeutics raises £2.9m to support further development of sevuparin for SCD
Modus Therapeutics has raised SEK32m (£2.9m) from existing investors KDev Investments, Östersjöstiftelsen and Praktikerinvest to support a phase two study of a sickle cell disease (SCD) drug.
Drug Research > Drug Discovery & Development > News
Versant Ventures launches biotechnology firm Jecure Therapeutics
Versant Ventures has launched Jecure Therapeutics, a biotechnology firm focused on the discovery of novel therapeutics to treat non-alcoholic steatohepatitis (NASH) and liver fibrosis.
Drug Research > Drug Discovery & Development > News
136-150 of 4506 results